IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-α production in macrophages
- 1 December 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 102 (12), 4123-4129
- https://doi.org/10.1182/blood-2003-04-1228
Abstract
Interleukin-10 (IL-10) plays an important role in prevention of chronic inflammation in vivo. However, the molecular mechanism by which IL-10 exerts its anti-inflammatory response is poorly understood. Here, we performed a microarray analysis and identified Bcl-3 as an IL-10-inducible gene in macrophages. Lentiviral vector-mediated expression of Bcl-3 inhibited lipopolysaccharide (LPS)-induced production of tumor necrosis factor α (TNF-α), but not IL-6, in macrophages. In Bcl-3-transduced and IL-10-pretreated macrophages, LPS-induced nuclear translocation of nuclear factor κB (NF-κB) p65 was not impaired. However, DNA binding by NF-κB p50/p65 was profoundly inhibited. Nuclear localization of Bcl-3 was associated with inhibition of LPS-induced TNF-α production. Overexpression of Bcl-3 suppressed activation of the TNF-α promoter, but not the IL-6 promoter. Bcl-3 interacted with NF-κB p50 and was recruited to the TNF-α promoter, but not the IL-6 promoter, indicating that Bcl-3 facilitates p50-mediated inhibition of TNF-α expression. Furthermore, Bcl-3-deficient macrophages showed defective IL-10-mediated suppression of LPS induction of TNF-α, but not IL-6. These findings suggest that IL-10-induced Bcl-3 is required for suppression of TNF-α production in macrophages. (Blood. 2003; 102:4123-4129)Keywords
This publication has 47 references indexed in Scilit:
- Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in miceNature Medicine, 2002
- NF-κB-inducible BCL-3 Expression Is an Autoregulatory Loop Controlling Nuclear p50/NF-κB1 ResidenceJournal of Biological Chemistry, 2001
- Interleukin-10 and the Interleukin-10 ReceptorAnnual Review of Immunology, 2001
- MAIL, a novel nuclear IκB protein that potentiates LPS‐induced IL‐6 productionFEBS Letters, 2000
- Interleukin-10 Receptor Signaling through the JAK-STAT PathwayJournal of Biological Chemistry, 1999
- Immunological defects in mice with a targeted disruption in Bcl-3.Genes & Development, 1997
- Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.Journal of Clinical Investigation, 1996
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimersCell, 1993
- The proto-oncogene bcl-3 encodes an I kappa B protein.Genes & Development, 1992